EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil

European Journal of Cancer

Volumn 43, Issue 3, 2007, Pages 520-526

  Na, Im Il ^a   Kang, Hye Jin ^a   Cho, Soo Youn ^a   Koh, Jae Soo ^a   Lee, Jin Kyung ^a   Lee, Byeong Cheol ^a   Lee, Guk Haeng ^a   Lee, Yong Sik ^a   Yoo, Hyung Jun ^a   Ryoo, Baek Yeol ^a   Yang, Sung Hyun ^a   Shim, Yoon Sang ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

EGFR; Head and neck cancer; Human papillomavirus; Mutation; Tongue cancer; Tonsillar cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; DNA MICROARRAY; EXON; FEMALE; GENE SEQUENCE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TONGUE CARCINOMA; TONSIL CARCINOMA; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; PAPILLOMAVIRUS INFECTIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS;

EID: 33846609066     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.09.025     Document Type: Article

References (30)

1. Shibuya K., Mathers C.D., Boschi-Pinto C., Lopez A.D., and Murray C.J. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2 (2002) 37
2. Mashberg A., Boffetta P., Winkelman R., and Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72 4 (1993) 1369-1375
3. Franceschi S., Talamini R., Barra S., et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 50 20 (1990) 6502-6507
4. Mork J., Lie A.K., Glattre E., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344 15 (2001) 1125-1131
5. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 9 (2000) 709-720
6. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 57 5 (2004) 449-455
7. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 32 Suppl 1 (2005) S59-S66
8. Marchetti A., Martella C., Felicioni L., et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 23 4 (2005) 857-865
9. Shigematsu H., Lin L., Takahashi T., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 5 (2005) 339-346
10. Cheng Y.W., Chiou H.L., Sheu G.T., et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61 7 (2001) 2799-2803
11. Wirth L.J., Haddad R.I., Lindeman N.I., et al. Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 23 28 (2005) 6976-6981
12. Lee J.W., Soung Y.H., Kim S.Y., et al. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res 11 8 (2005) 2879-2882
13. An H.J., Cho N.H., Lee S.Y., et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97 7 (2003) 1672-1680
14. An H.J., Kim K.R., Kim I.S., et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 18 4 (2005) 528-534
15. Han S.W., Kim T.Y., Hwang P.G., et al. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 23 11 (2005) 2493-2501
16. Chang A., Wu H., Park C., et al. Retrospective analysis of the treatment results for patients with squamous cell carcinoma of tonsil. Cancer Res Treat 37 2 (2005) 92-97
17. Wu Y., Chen Y., Li L., et al. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35 3 (2006) 264-269
18. Kobayashi S., Boggon T.J., Dayaram T., et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352 8 (2005) 786-792
19. Cohen E.E., Rosen F., Stadler W.M., et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 21 10 (2003) 1980-1987
20. Shepherd F.A., Rodrigues Pereira J., Ciuleanu T., et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353 2 (2005) 123-132
21. Eberhard D.A., Johnson B.E., Amler L.C., et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol 23 25 (2005) 5900-5909
22. Jackman D.M., Yeap B.Y., Sequist L.V., et al. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clin Cancer Res 12 13 (2006) 3908-3914
23. Pytynia K.B., Grant J.R., Etzel C.J., et al. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol 22 19 (2004) 3981-3988
24. Niedobitek G., Pitteroff S., Herbst H., et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 43 11 (1990) 918-921
25. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 32 Suppl 1 (2005) S59-S66
26. Dahlgren L., Dahlstrand H.M., Lindquist D., et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 112 6 (2004) 1015-1019
27. Ritchie J.M., Smith E.M., Summersgill K.F., et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104 3 (2003) 336-344
28. Butz K., Geisen C., Ullmann A., Spitkovsky D., and Hoppe-Seyler F. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis. Int J Cancer 68 4 (1996) 506-513
29. DeWeese T.L., Walsh J.C., Dillehay L.E., et al. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation. Int J Radiat Oncol Biol Phys 37 1 (1997) 145-154
30. Ferris R.L., Martinez I., Sirianni N., et al. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer 41 5 (2005) 807-815